Preliminary results of a phase I trial using retroviral gene transfer of G156A MGMT to protect hematopoiesis during BG and BCNU therapy of advanced malignancies

被引：0
|
作者：
Reese, J [1 ]
Lingas, K [1 ]
Ksenich, P [1 ]
Sweeney, C [1 ]
Koc, O [1 ]
Gerson, S [1 ]
机构：
[1] Case Western Reserve Univ, Ctr Stem Cell & Regenerat Med, Case Comprehens Canc Ctr, Sch Med, Cleveland, OH 44106 USA
来源：
MOLECULAR THERAPY | 2004年 / 9卷
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
1006
引用
收藏
页码：S385 / S385
页数：1
相关论文
共 7 条
  • [1] Safety of MGMT gene transfer into hematopoictic progenitors: A phase I clinical trial using retroviral gene transfer of G156A MGMT to protect hematopoiesis during BG plus alkylating agent treatment of advanced malignancies
    Reese, Jane S.
    Lingas, Karen T.
    Sweeney, Colin L.
    Brell, Joanna M.
    Gerson, Stanton L.
    BLOOD, 2007, 110 (11) : 154A - 154A
  • [2] Retrovirus insertion site analysis following in vivo drug selection in a phase I clinical trial utilizing G156A MGMT for enhanced chemotherapy of advanced malignancies.
    Sweeney, CL
    Lingas, K
    Reese, JS
    Flick, S
    Gerson, SL
    BLOOD, 2005, 106 (11) : 853A - 853A
  • [3] The First Phase I Human Gene Transfer Trial: Ion Channel Therapy for the treatment ED-Preliminary Results
    Melman, Arnold
    Bar-Chama, Natan
    Christ, George
    Davies, Kelvin
    JOURNAL OF SEXUAL MEDICINE, 2004, 1 : 14 - 16
  • [4] Results from one year follow up of a phase I trial of FVIII gene transfer for severe hemophilia A using a retroviral construct administered by peripheral intravenous infusion.
    Powell, JS
    Ragni, MV
    White, GC
    Lusher, J
    Hillman-Wiseman, C
    Cole, V
    Jolly, D
    Ramanathan-Girish, S
    Roehl, H
    Lu, B
    Hurst, D
    BLOOD, 2001, 98 (11) : 693A - 693A
  • [5] Intraprostatic interleukin-2 (IL-2) gene therapy: Preliminary results of a phase I clinical trial for the treatment of locally advanced prostate cancer (CaP).
    Naitoh, J
    Tso, CL
    Kaboo, R
    Stiles, A
    Figlin, R
    Belldegrun, A
    JOURNAL OF UROLOGY, 1998, 159 (05): : 254 - 254
  • [6] HPC GENE THERAPY FOR GBM: AUTOLOGOUS LENTIVIRAL TRANSDUCED P140K-MGMT HEMATOPOIETIC PROGENITOR CELLS (HPCS) FOR BONE MARROW CHEMOPROTECTION COMBINED WITH O6-BENZYLGUANINE (BG) AND TEMOZOLOMIDE (TMZ) THERAPY FOR GLIOBLASTOMA MULTIFORME (GBM). PRELIMINARY RESULTS OF A PHASE I CLINICAL TRIAL
    Sloan, Andrew E.
    Reese, Jane
    Rogers, Lisa R.
    Embree, Heather
    Lazarus, Hillard M.
    Fung, Hua
    Kane, Dona
    Dropulic, Boro
    Gerson, Stanton L.
    NEURO-ONCOLOGY, 2012, 14 : 103 - 103
  • [7] GO-8: Preliminary Results of a Phase I/II Dose Escalation Trial of Gene Therapy for Haemophilia a Using a Novel Human Factor VIII Variant
    Nathwani, Amit C.
    Tuddenham, Edward
    Chowdary, Pratima
    McIntosh, Jenny
    Lee, Doyoung
    Rosales, Cecilia
    Phillips, Mark
    Pie, Jun
    Zhou Junfang
    Meagher, Michael M.
    Reiss, Ulrike
    Davidoff, Andrew M.
    Morton, Chris L.
    Riddell, Anne
    BLOOD, 2018, 132
1